BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04310397-completion@plaintrial.com
DTSTAMP:20260928T095021Z
DTSTART;VALUE=DATE:20231009
SUMMARY:Dabrafenib\, Trametinib\, and Spartalizumab for the Treatment of BR
 AF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma — estimated 
 completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT04310397
URL:https://plaintrial.com/trial/NCT04310397
END:VEVENT
END:VCALENDAR